Hemodialysis Market
Improving Dialysis Care
Catheter-related bloodstream infections, occlusion, and leakage are common complications among hemodialysis patients with central venous catheters. The Lyka® PORT needlefree access device is designed to minimize these risks and improve patient safety.
Uniquely designed for use in hemodialysis, the Lyka® PORT1 brings engineering excellence to patient care, safety, and performance. The Lyka® PORT needlefree access device utilizes split septum technology with low dead space, and is fully flushable to reduce infection risk. The CDC recommends split septum valves over mechanical valves in needleless systems to reduce infection risk. The Lyka® PORT features a split septum with low dead space and an open fluid path, delivering ultra-high flow rates and enhanced safety for hemodialysis patients2.
References
1 Lyka® PORT is FDA 510(k) cleared for use with vascular access devices in hemodialysis or as an accessory to an I.V. set for the administration or withdraw of fluids to a patient through a cannula or needle placed in the vein or artery. The device may be used for patient populations including very low birth-weight infants, infants, children, and adults for up to 7 days.
2 O-Grady, Naomi, et al. “Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011.” U.S. Centers for Disease Control and Prevention, 2011, pp. 19.